Status:
UNKNOWN
Neurodevelopmental Disorders in Children With Systemic Inflammatory Disease
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Neurodevelopmental Disorders
Eligibility:
All Genders
5-17 years
Brief Summary
Systemic inflammatory diseases in children include autoinflammatory diseases (deregulation of the innate immune system with production of pro-inflammatory cytokines) and autoimmune diseases (deregulat...
Detailed Description
Systemic inflammatory diseases in children include auto-inflammatory diseases (deregulation of the innate immune system with production of pro-inflammatory cytokines) and autoimmune diseases (deregula...
Eligibility Criteria
Inclusion
- Any patient with a systemic inflammatory disease
- Age between 5 and 17 years old
- Parents informed and having signed a consent or having consented orally in case of absence of one of the two parents
Exclusion
- Insufficient comprehension of the French language
- Mental retardation with IQ \<30
- Not affiliated to a social security system
Key Trial Info
Start Date :
December 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 6 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04814862
Start Date
December 6 2021
End Date
December 6 2022
Last Update
October 18 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.